Drug intelligence / Profile preview

polyvalent human immunoglobulin

Development stage
Approved
Lead developer
Biotest
Administration
Intravenous, Subcutaneous
01

Overview

Polyvalent human immunoglobulin is a purified form of human immunoglobulin G and other proteins derived from pooled human plasma from thousands of donors. It contains primarily IgG (with four subclasses: IgG1, IgG2, IgG3, and IgG4) and works through multiple mechanisms including Fc-dependent and F(ab')2-dependent actions. It interacts with cytokines, complement, Fc receptors, and several cell surface immunocompetent molecules, impacting different effector cells of the immune system and regulating a wide range of genes. IVIG is used for replacement therapy in immunodeficiency disorders and as an immunomodulator in various autoimmune and inflammatory conditions.

Brand names
PrivigenPanzygaAlygloHyqvia
Other names
intravenous immunoglobulinIVIGimmune globulin intravenoushuman immunoglobulin G
02

Targets

FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)

Beyond the preview

Go deeper on polyvalent human immunoglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyvalent human immunoglobulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call